Warrant

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Retrieved on: 
Monday, April 22, 2024
Sale, Prospectus, Ovarian cancer, Warrant, GTG, Regulation D, Health, 3rd Floor, ASX, Research, Genetic testing, Form, ADS, American depositary receipt, B2B, Security (finance)

MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares (“ADSs”) (or ADS equivalents in lieu thereof), each representing thirty (30) ordinary shares of the Company, at an offering price of US$2.00 per ADS.

Key Points: 
  • The gross proceeds to the Company from this offering were approximately US$2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The offering of the ADSs (or ADS equivalents) in the registered direct offering were made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering were filed with the SEC.
  • Authorised for release by the Board of Directors of Genetic Technologies Limited.

Alternus Clean Energy, Inc. Announces Closing of $2.16 Million Private Placement of Convertible Notes and Warrants

Retrieved on: 
Monday, April 22, 2024
Sale, Warrant, United, Note, Public expenditure, Exercise, Security (finance)

The investment is in the form of a Senior Unsecured Original Issue 8% Discount Convertible Note (the “Note”), resulting in proceeds before expenses to Alternus of approximately $2.0 million.

Key Points: 
  • The investment is in the form of a Senior Unsecured Original Issue 8% Discount Convertible Note (the “Note”), resulting in proceeds before expenses to Alternus of approximately $2.0 million.
  • The Company expects to use the proceeds from this offering to continue executing on its business plan, including funding planned capital expenditures and working capital.
  • Maxim Group LLC acted as the exclusive placement agent for the private placement.
  • You may also obtain these documents for free when they are available by visiting the SEC's web site at www.sec.gov .

Xtract One Announces Upsized Public Offering and Concurrent Investment by Strategic Partner

Retrieved on: 
Monday, April 22, 2024
Sale, Indian stock exchange, Warrant, Person, Offering, PP, Private, XTRA, TSX, NEWS, Agent, Toronto Stock Exchange, Exercise, Sport, Prospectus, FRA, Security (finance)

TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) is pleased to announce that it has increased the size of its previously announced public offering (the “Offering”). The Offering is being conducted by Eight Capital, as lead agent and sole bookrunner, and Echelon Wealth Partners Inc. (together with Eight Capital, the “Agents”) pursuant to which the Agents have agreed to conduct the Offering on a commercially reasonable best efforts basis.

Key Points: 
  • TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) is pleased to announce that it has increased the size of its previously announced public offering (the “Offering”).
  • Each Unit will consist of one common share of the Company (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”).
  • Closing of the Offering is not conditional on the closing of the Concurrent Private Placement.
  • Xtract One intends to use the proceeds of the Offering and the Concurrent Private Placement for working capital and general corporate purposes.

GFG Closes Private Placement Financing

Retrieved on: 
Friday, April 19, 2024
Sale, Part, Warrant, NOT, GFG, Offering, Brookfield Place, News, Acceleration, Suite, AGI, Issuer, TSX, Income Tax Act, Exercise, Senior, National instrument, Minority, Security (finance)

SASKATOON, Saskatchewan, April 19, 2024 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has closed its private placement financing (the “Offering”) (see news release dated February 23, 2024) for gross proceeds of C$2,505,866. In connection with the Offering, Alamos Gold Inc. (“Alamos”) (TSX: AGI; NYSE: AGI) purchased securities to maintain their 9.9% interest in the Company.

Key Points: 
  • NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
    SASKATOON, Saskatchewan, April 19, 2024 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has closed its private placement financing (the “Offering”) (see news release dated February 23, 2024 ) for gross proceeds of C$2,505,866.
  • In connection with the Offering, GFG management and directors of the Company (collectively the “Insiders”), purchased a total of 3,200,000 Units and 497,000 FT Units.
  • Prior to the closing of the Offering, Alamos held 20,809,004 common shares and 3,843,303 warrants of GFG, representing a security holding percentage of approximately 11.24%, on a partially diluted basis.
  • Following the closing of the Offering, Alamos will have beneficial ownership of, or control and direction over 23,809,004 common shares and 5,343,303 warrants of GFG.

PharmAla Closes Private Placement and Concurrent Debt Settlement

Retrieved on: 
Friday, April 19, 2024
Sale, Indian stock exchange, Warrant, Offering, Date, Nature, OTC, Debt, Research, MDMA, Unit, MDXX, Security (finance)

Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 10 Release.

Key Points: 
  • Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 10 Release.
  • Each Unit was sold at a price of $0.18 per Unit and consisted of one Common Share and one-half of one Warrant.
  • The Common Shares issued in connection with the Debt Settlement are subject to a statutory hold period of four months and one day from the date of issuance.
  • The Company did not file a material change report more than 21 days before the closing date of the Offering.

Genetic Technologies Announces $2 Million Registered Direct Offering

Retrieved on: 
Thursday, April 18, 2024
Sale, Prospectus, Ovarian cancer, Warrant, GTG, Regulation D, Health, 3rd Floor, ASX, Research, Genetic testing, Form, ADS, American depositary receipt, B2B, Security (finance)

The closing of the offering is expected to occur on or about April 22, 2024, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about April 22, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from this offering are expected to be approximately $2 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The offering of the ADSs (or ADS equivalents) in the registered direct offering will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC.

Xtract One Announces Terms of Public Offering and Concurrent Investment by Strategic Partner

Retrieved on: 
Thursday, April 18, 2024
Sale, Indian stock exchange, Warrant, Person, Offering, PP, Private, XTRA, TSX, NEWS, Agent, Toronto Stock Exchange, Exercise, Sport, Prospectus, FRA, Security (finance)

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) is pleased to announce that it has priced its previously announced public offering (the “Offering”). The Offering is being conducted by Eight Capital, as lead agent and sole bookrunner, and Echelon Wealth Partners Inc. (together with Eight Capital, the “Agents”) pursuant to which the Agents have agreed to conduct the Offering on a commercially reasonable best efforts basis.

Key Points: 
  • TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) is pleased to announce that it has priced its previously announced public offering (the “Offering”).
  • Pursuant to the Offering, the Company intends to issue units (each, a “Unit”) at a price of $0.51 per Unit for gross proceeds of up to $5 million.
  • Closing of the Offering is not conditional on the closing of the Concurrent Private Placement.
  • Xtract One intends to use the proceeds of the Offering and the Concurrent Private Placement for working capital and general corporate purposes.

Kartoon Studios Inc. Announces Pricing of up to $7 Million Registered Direct Offering of Common Stock

Retrieved on: 
Thursday, April 18, 2024
Sale, Prospectus, Warrant, SPA, Madison Avenue, Form, EF Hutton, Attention, Telephone, Security (finance)

EF Hutton LLC is acting as the sole placement agent for the offering.

Key Points: 
  • EF Hutton LLC is acting as the sole placement agent for the offering.
  • The securities are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No.
  • The offering is being made only by means of a prospectus supplement and accompanying prospectus.
  • Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.

Hapbee Announces Closing of Private Placement

Retrieved on: 
Thursday, April 18, 2024
Warrant, Person, Offering, Acceleration, News, Share (finance), HA1, CAD, Regulation, Rule, TSX Venture Exchange, Security (finance)

VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company (“Units”) for aggregate gross proceeds to the Company of CAD$2,785,000 (the “Offering”).

Key Points: 
  • VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company (“Units”) for aggregate gross proceeds to the Company of CAD$2,785,000 (the “Offering”).
  • “This capital enables us to continue to evolve our products and to expand our market presence and manufacturing” said Yona Shtern, CEO and Executive Chairman of Hapbee.
  • The Company is also delighted to welcome Jaylen Brown who will join Hapbee as Chief Innovation Officer and Rizwan Shah who will join as Chief Commercial Officer, both participated in the round.
  • The securities offered pursuant to the Offering have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S.

Xtract One Announces Marketed Public Offering of Units and Concurrent Investment by Strategic Partner

Retrieved on: 
Wednesday, April 17, 2024
Sale, Warrant, Unit, Person, Offering, Private, XTRA, Agent, TSX, NEWS, Multilateral, Toronto Stock Exchange, Sport, Minority, Letter, FRA, Security (finance)

TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) is pleased to announce that it has entered into an engagement letter with Eight Capital (the “Agent”) pursuant to which the Agent has agreed to conduct a public offering of units (the “Units”) on a “commercially reasonable best-efforts” marketed basis (the “Offering”). Each Unit shall consist of one common share in the capital of the Company (each, a “Share”) and one common share purchase warrant (each, a “Warrant”). The number of Units to be sold and amount of proceeds to be raised under the Offering will be determined in the context of the market. There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Key Points: 
  • The number of Units to be sold and amount of proceeds to be raised under the Offering will be determined in the context of the market.
  • There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
  • Closing of the Offering is not conditional on the closing of the Concurrent Private Placement.
  • Xtract One intends to use the proceeds of the Offering and the Concurrent Private Placement for working capital and general corporate purposes.